{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T19:27:21Z","timestamp":1759778841608,"version":"3.44.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"crossref","award":["2010CB529806"],"award-info":[{"award-number":["2010CB529806"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30873179","81272569"],"award-info":[{"award-number":["30873179","81272569"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"crossref","award":["09QA1403500"],"award-info":[{"award-number":["09QA1403500"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Pujiang Program","award":["12PJD023"],"award-info":[{"award-number":["12PJD023"]}]},{"DOI":"10.13039\/501100003399","name":"Shanghai Municipal Science and Technology Commission","doi-asserted-by":"crossref","award":["11ZR1419900","11430702200"],"award-info":[{"award-number":["11ZR1419900","11430702200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Innovation Program of Shanghai Municipal Education Commission","award":["11YZ53","12ZZ200","13ZZ087"],"award-info":[{"award-number":["11YZ53","12ZZ200","13ZZ087"]}]},{"DOI":"10.13039\/501100007279","name":"Shanghai Municipal Health Bureau","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007279","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003024","name":"Shanghai Education Development Foundation","doi-asserted-by":"crossref","award":["10CGB03"],"award-info":[{"award-number":["10CGB03"]}],"id":[{"id":"10.13039\/501100003024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.biomaterials.2013.02.017","type":"journal-article","created":{"date-parts":[[2013,3,4]],"date-time":"2013-03-04T22:48:04Z","timestamp":1362437284000},"page":"3925-3937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["The use of nanoparticulate delivery systems in metronomic chemotherapy"],"prefix":"10.1016","volume":"34","author":[{"given":"De-Hong","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Qiang","family":"Ban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan F.","family":"Lovell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Yun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Luan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Zhuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2013.02.017_bib1","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra0706596","article-title":"Tumor angiogenesis","volume":"358","author":"Kerbel","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib2","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm.2537","article-title":"Tumor angiogenesis: molecular pathways and therapeutic targets","volume":"17","author":"Weis","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1021\/nl902659g","article-title":"Synergistic targeting of alphavbeta3 integrin and galectin-1 with heteromultivalent paramagnetic liposomes for combined MR imaging and treatment of angiogenesis","volume":"10","author":"Kluza","year":"2010","journal-title":"Nano Lett"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib5","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/anie.201106527","article-title":"A\u00a0traceless vascular-targeting antibody-drug conjugate for cancer therapy","volume":"51","author":"Bernardes","year":"2012","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrc1369","article-title":"The anti-angiogenic basis of metronomic chemotherapy","volume":"4","author":"Kerbel","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrclinonc.2010.82","article-title":"Metronomic chemotherapy: new rationale for new directions","volume":"7","author":"Pasquier","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/gutjnl-2011-301585","article-title":"Metronomic oral topotecan prolongs survival and reduces liver metastasis in improved preclinical orthotopic and adjuvant therapy colon cancer models","volume":"62","author":"Hackl","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1593\/neo.101186","article-title":"Metronomic S-1 chemotherapy and vandetanib: an efficacious and nontoxic treatment for hepatocellular carcinoma","volume":"13","author":"Iwamoto","year":"2011","journal-title":"Neoplasia"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ijc.24846","article-title":"Vascular targeting by EndoTAG-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer","volume":"126","author":"Eichhorn","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib11","first-page":"7400","article-title":"Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy","volume":"63","author":"Pastorino","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib12","first-page":"417","article-title":"In\u00a0vitro pharmacological characterizations of the anti-angiogenic and anti-tumor cell migration properties mediated by microtubule-affecting drugs, with special emphasis on the organization of the actin cytoskeleton","volume":"21","author":"Hayot","year":"2002","journal-title":"Int J Oncol"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.drup.2006.04.003","article-title":"Microtubule-targeting agents in angiogenesis: where do we stand?","volume":"9","author":"Pasquier","year":"2006","journal-title":"Drug Resist Update"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib14","doi-asserted-by":"crossref","first-page":"566","DOI":"10.2174\/156800907781662266","article-title":"Targeting microtubules to inhibit angiogenesis and disrupt tumour vasculature: implications for cancer treatment","volume":"7","author":"Pasquier","year":"2007","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib15","doi-asserted-by":"crossref","first-page":"46681","DOI":"10.1074\/jbc.M308681200","article-title":"A\u00a0vascular endothelial growth factor high affinity receptor 1-specific peptide with antiangiogenic activity identified using a phage display peptide library","volume":"278","author":"El-Mousawi","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib16","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.biomaterials.2009.11.047","article-title":"Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature","volume":"31","author":"Yu","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejps.2005.08.002","article-title":"In\u00a0vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size","volume":"27","author":"Fang","year":"2006","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib18","doi-asserted-by":"crossref","first-page":"W249","DOI":"10.1093\/nar\/gkr431","article-title":"Rosetta FlexPepDock web server-high resolution modeling of peptide-protein interactions","volume":"39","author":"London","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.nano.2011.05.008","article-title":"The in\u00a0vivo behavior and antitumor activity of doxorubicin-loaded poly(\u03b3-benzyl l-glutamate)-block-hyaluronan polymersomes in ehrlich ascites tumor-bearing BalB\/c mice","volume":"8","author":"Upadhyay","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.biopha.2011.04.013","article-title":"Interleukin 1 receptor antagonist reduces lethality and intestinal toxicity of 5-fluorouracil in a mouse mucositis model","volume":"65","author":"Wu","year":"2011","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0092-8674(00)80456-0","article-title":"Crystal structure at 1.7\u00a0\u00c5 resolution of VEGF in complex with domain 2 of the Flt-1 receptor","volume":"91","author":"Wiesmann","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib22","doi-asserted-by":"crossref","first-page":"10382","DOI":"10.1074\/jbc.M313237200","article-title":"The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1","volume":"279","author":"Christinger","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib23","doi-asserted-by":"crossref","first-page":"12917","DOI":"10.1073\/pnas.2135406100","article-title":"Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy","volume":"100","author":"Bocci","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1158\/1535-7163.MCT-07-0584","article-title":"Modulation of the antitumor activity of metronomic cyclophosphamide by the angiogenesis inhibitor axitinib","volume":"7","author":"Ma","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib25","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","article-title":"PEGylation, successful approach to drug delivery","volume":"10","author":"Veronese","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib26","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1074\/jbc.M507401200","article-title":"Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1","volume":"281","author":"Cai","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib27","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1096\/fj.03-0767fje","article-title":"The c-Cbl\/CD2AP complex regulates VEGF-induced endocytosis and degradation of Flt-1 (VEGFR-1)","volume":"18","author":"Kobayashi","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib28","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/01.RES.0000214545.99387.e3","article-title":"Vesicular trafficking of tyrosine kinase receptors and associated proteins in the regulation of signaling and vascular function","volume":"98","author":"Mukherjee","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1034\/j.1600-0854.2002.30501.x","article-title":"Endocytosis via caveolae","volume":"3","author":"Pelkmans","year":"2002","journal-title":"Traffic"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib30","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.addr.2007.06.008","article-title":"Endocytic mechanisms for targeted drug delivery","volume":"59","author":"Bareford","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrm2122","article-title":"The multiple faces of caveolae","volume":"8","author":"Parton","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib32","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/jcb.22584","article-title":"A\u00a0novel intracellular isoform of VEGFR-1 activates Src and promotes cell invasion in MDA-MB-231 breast cancer cells","volume":"110","author":"Mezquita","year":"2010","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib33","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1349-7006.2010.01807.x","article-title":"Metronomic irinotecan chemotherapy combined with ultrasound irradiation for a human uterine sarcoma xenograft","volume":"102","author":"Choijamts","year":"2011","journal-title":"Cancer Sci"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib34","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1158\/1535-7163.MCT-09-0960","article-title":"Potent preclinical impact of metronomic low-dose oral topotecan combined with the antiangiogenic drug pazopanib for the treatment of ovarian cancer","volume":"9","author":"Hashimoto","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib35","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1158\/1078-0432.CCR-04-2271","article-title":"Differential effects of vascular endothelial growth factor receptor-2 inhibitor ZD6474 on circulating endothelial progenitors and mature circulating endothelial cells: implications for use as a surrogate marker of antiangiogenic activity","volume":"11","author":"Beaudry","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib36","first-page":"4342","article-title":"Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells","volume":"63","author":"Bertolini","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.biomaterials.2013.02.017_bib37","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood-2005-04-1422","article-title":"Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity","volume":"106","author":"Shaked","year":"2005","journal-title":"Blood"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961213001865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961213001865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:48:15Z","timestamp":1758901695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961213001865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":37,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0142961213001865"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2013.02.017","relation":{},"ISSN":["0142-9612"],"issn-type":[{"type":"print","value":"0142-9612"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of nanoparticulate delivery systems in metronomic chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2013.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}